Genus’ (GNS) “Buy” Rating Reiterated at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Genus (LON:GNS) in a research report released on Thursday morning,Digital Look reports. The brokerage currently has a GBX 3,350 target price on the stock.

Genus Stock Up 1.5%

Shares of GNS stock opened at GBX 2,192 on Thursday. The company has a market capitalization of £1.46 billion, a price-to-earnings ratio of 30.87, a PEG ratio of 2.87 and a beta of 0.90. Genus has a one year low of GBX 1,943 and a one year high of GBX 3,220. The company’s fifty day moving average price is GBX 2,220.31 and its 200-day moving average price is GBX 2,374.09. The company has a debt-to-equity ratio of 14.02, a current ratio of 2.22 and a quick ratio of 1.08.

Genus (LON:GNS) last released its earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share for the quarter. Genus had a net margin of 43.35% and a return on equity of 44.90%. Sell-side analysts expect that Genus will post 70.9644323 EPS for the current fiscal year.

Insider Activity

In other Genus news, insider Celia Baxter bought 2,336 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was purchased at an average price of GBX 2,140 per share, for a total transaction of £49,990.40. Corporate insiders own 0.71% of the company’s stock.

More Genus News

Here are the key news stories impacting Genus this week:

• Positive Sentiment: Genus reported higher FY26 pretax profit, reduced leverage and launched a £60 million share buyback. The repurchase signals management confidence in the company’s long-term growth prospects and could support earnings per share. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: Berenberg reaffirmed its Buy rating and set a GBX 3,350 price target, implying substantial upside from recent trading levels. Genus announces £60m buyback as FY profits rise
• Neutral Sentiment: Genus posted quarterly EPS of GBX 110.30, with a 9.70% return on equity and 7.07% net margin. The results provide evidence of profitability, but the market reaction indicates investors were more concerned about forward guidance and revenue performance. Genus quarterly earnings
• Negative Sentiment: Management forecast moderate FY27 operating-profit growth, while FY26 revenue missed expectations. The combination has raised concerns about slower near-term momentum, outweighing the improved profit, lower debt and buyback news. Genus Shares Fall as Company Forecasts Moderate FY27 Growth

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.